Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CEDRA | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

CEDRA

Thomas L. Lloyd has been appointed director of automation for the Bioanalytical Group of CEDRA Corp.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thomas L. Lloyd has been appointed director of automation for the Bioanalytical Group of CEDRA Corp. Mr. Lloyd has more than 22 years of industry experience developing and automating analytical and bioanalytical processes. He has specific expertise in the areas of automation systems and analytical instrument development, bioanalytical chemistry, in vitro DMPK studies, software programming and application, statistics, chemometrics and GLP requirements.

Prior to joining the company, Mr. Lloyd led the automation group at Pfizer, previously as Wyeth Research. He has held previous positions at DuPont Merck Pharmaceutical Co. and GlaxoSmithKline.

“Thomas is an enormous asset to the CEDRA team,” said CEDRA chief executive officer, Anthony G. Busa, Jr. “His extensive industry experience and knowledge in developing and automating analytical and bioanalytical processes are energizing to our team, and his passion for excellence and superior client satisfaction are elevating our offerings to the next level. We are very excited to have him with us and are looking forward to his contributions.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics